Comparsion of Coccydynia treatment with intractal manipulation concomitant to methyl prednisolone acetate injection & manipulation.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT138811203317N1

Enrollment

Registered

2010-04-03

Start date

2009-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coccydynia. Sacrococcygeal Disorders not elsewhere classified Coccygodynia

Interventions

Intervention 1: Coccygeal Manipulation concomitant with methyl prednisolone acetate injection (40mg). Intervention 2: Three sessions of coccygeal manipulation.

Treatment - Drugs

Coccygeal Manipulation concomitant with methyl prednisolone acetate injection (40mg)

Three sessions of coccygeal manipulation

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Presence of chronic (>2 months) Coccydynia, age between 18 and 70, no prior other treatments, consent to the study. Exclusion criteria: Presence of acute fracture of coccyx, Presence of osteoporosis, diabetes, or rheumatologic Disorders, known malignancy or congenital malformations.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Coccydynia treatment. Timepoint: One day, One week, One month & three months after the procedure. Method of measurement: Using a VAS and paris (functional Coccydinia impact) questionnaires.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammadjavad Hadianfard

Shiraz University of Medical Sciences and Health Services

?hadianj@sums.ac.ir+98 71 1230 0040

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026